The COVID-19 virus has spread to over 100 nations since its outbreak in December 2019, prompting the World Health Organization to designate it a public health emergency. As of August 2, 2021, the manifestation of Coronavirus (COVID-19) had resulted in more than 198 million infected individuals worldwide, according to a World Health Organization report.
COVID-19 has the potential to impact the economy in three ways: directly impacting production and demand, causing distribution channel disruptions, and having a financial impact on enterprises and financial markets. Several countries, including China, India, Saudi Arabia, the United Arab Emirates, Egypt, and others, are experiencing difficulties transporting narcotics from one location to another as a result of nationwide lockdowns.
Furthermore, the COVID-19 pandemic is posing significant difficulties to participants in the global bone cancer medication industry on multiple fronts. The supply of raw materials required for producing medication formulations is a big difficulty due to transportation anomalies. Furthermore, due to a surge in the number of patients suffering from COVID-19 and other life-threatening conditions, distributors are seeing erratic demand for items from retailers.
Click here for Bone Cancer Drugs Market Report: